TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $834,000 | +39.9% | 11,572 | +6.6% | 0.00% | 0.0% |
| Q3 2020 | $596,000 | -17.5% | 10,857 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $722,000 | -23.4% | 10,857 | -29.6% | 0.00% | -50.0% |
| Q1 2020 | $943,000 | -30.9% | 15,420 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,365,000 | +17.4% | 15,420 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,163,000 | -55.0% | 15,420 | -49.0% | 0.00% | -60.0% |
| Q2 2019 | $2,585,000 | +0.3% | 30,261 | +26.9% | 0.01% | 0.0% |
| Q1 2019 | $2,577,000 | +65.0% | 23,837 | +29.2% | 0.01% | +66.7% |
| Q4 2018 | $1,562,000 | +407.1% | 18,453 | +574.2% | 0.00% | – |
| Q3 2017 | $308,000 | -12.5% | 2,737 | -12.8% | 0.00% | -100.0% |
| Q2 2017 | $352,000 | +33.3% | 3,140 | +38.8% | 0.00% | 0.0% |
| Q1 2017 | $264,000 | -0.4% | 2,263 | -10.2% | 0.00% | 0.0% |
| Q4 2016 | $265,000 | +6.0% | 2,519 | +11.5% | 0.00% | 0.0% |
| Q3 2016 | $250,000 | -48.1% | 2,260 | -31.7% | 0.00% | 0.0% |
| Q2 2016 | $482,000 | +72.1% | 3,311 | +69.3% | 0.00% | 0.0% |
| Q1 2016 | $280,000 | -14.1% | 1,956 | -7.3% | 0.00% | 0.0% |
| Q4 2015 | $326,000 | – | 2,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |